Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional

Safety and Efficacy Study of Rebamipide 2% Ophthalmic Suspension in Subjects With Dry Eye - Effects on Central Cornea

ClinicalTrials.gov ID: NCT01057147

Public ClinicalTrials.gov record NCT01057147. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 21, 2026, 4:47 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase II, Prospective, Randomized, Double-masked, Parallel Group, Multi-center Study Assessing the Safety and Efficacy of 2% Rebamipide (OPC-12759) Compared to Placebo in Clearing of Fluorescein Staining of the Central Cornea in Subjects With Keratoconjunctivitis Sicca (Dry Eye)

Study identification

NCT ID
NCT01057147
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Kubota Vision Inc.
Industry
Enrollment
116 participants

Conditions and interventions

Interventions

  • rebamipide 2% ophthalmic suspension Drug
  • placebo eye drops Drug

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jan 31, 2010
Primary completion
Dec 31, 2010
Completion
Jan 31, 2011
Last update posted
Jan 10, 2012

2010 – 2011

United States locations

U.S. sites
19
U.S. states
13
U.S. cities
17
Facility City State ZIP Site status
East Valley Ophthalmology Mesa Arizona 85206
Arizona Center for Clinical Trials, LLC Phoenix Arizona 85003
Cornea Consultants of Arizona Phoenix Arizona 85032
Macy Eye Center Los Angeles California 90048
Corneal Consultants of Colorado Littleton Colorado 80120
Specialty Eye Care Parker Colorado 80134
Cohen Laser and Vision Center Boca Raton Florida 33431
Florida Eye Microsurgical Institute, Inc. Boynton Beach Florida 33426
Med Eye Associates Miami Florida 33143
George R. John, MD Louisville Kentucky 40205
Central Maine Eye Care Lewiston Maine 04240
Ora, Inc. Andover Massachusetts 01810
Ophthalmology Associates St Louis Missouri 63131
Nevada Eye Care Professionals Las Vegas Nevada 89119
Avista Eye Center Las Vegas Nevada 89131
New York Ophthalmology, PC Manhasset New York 11030
Mundorf Eye Center Charlotte North Carolina 28204
Black Hills Regional Eye Institute Rapid City South Dakota 57701
The Cataract & Glaucoma Center El Paso Texas 79902

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT01057147, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jan 10, 2012 · Synced Jul 21, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT01057147 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →